The luxury skincare brand Element Eight has closed $6 million in new SAFE funding and announced several new appointments, including former Sephora Chief Executive Martin Brok as a board member.
WHO: Founded in 2022 by Gerard Camme and led by Chairman Bradley Patt, Element Eight is bringing advances in oxygen-infusing medicine to skincare. The team spent over a decade developing proprietary OATH: Oxygen Amplified Therapy technology, which mimics the function of hemoglobin to deliver more oxygen directly to skin cells up to 700 microns deep, counteracting the key signs of aging, all of which are caused by oxygen depletion in the skin. Collectively they hold 16 MD-PHDs, 120 medical patents, and over 100,000 uses of technologies they have developed. The brand has six stock-keeping items priced from $90 to $325 sold on its own website and in Bergdorf Goodman and Neiman Marcus.
WHY: The new funds will be used to continue accelerating the growth of the business.
IN THEIR OWN WORDS: Bradley Patt, company Chairman and co-founder, said, "With 45% of the round coming from surgeons, dermatologists, and PhD scientists, we have a strong validation of the scientific acumen of the brand. We were very pleased to also have participation from private family offices with experience in beauty investing, who accounted for 34% of the round. Finally, realizing fourteen percent participation from management, employees and members of the company's board of directors shows excitement about the company's progress from the people inside."
Founder and board member Gerard Camme said, "Element Eight has a unique point of difference thanks to the innovative technology of Oath, and fits into the fastest growing segment of the global skin care market. As we look ahead, we're excited to continue to innovate on the groundbreaking advances of our multi-expert team to bring new products to market and make Element Eight accessible on a wider scale."
DETAILS:
